---
title: "Life360, Inc. Stock 12‑Month Price Target Raised to $63.28, Implies 2% Downside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295520190.md"
description: "Analysts have raised the average 12-month price target for Life360, Inc. stock from $62.91 to $63.28, based on estimates from eight analysts. The new target implies a 2% downside from the August 10 closing price. The consensus rating remains 'Buy' among ten covering analysts, with eight recommending buys and two holding."
datetime: "2026-08-11T10:20:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295520190.md)
  - [en](https://longbridge.com/en/news/295520190.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295520190.md)
generator: "portal-rs"
---

# Life360, Inc. Stock 12‑Month Price Target Raised to $63.28, Implies 2% Downside

-   According to estimates from 8 analysts, Life360, Inc. stock's average price target has risen from $62.91 to $63.28, with forecasts ranging from $47 to $72 per share
-   Based on the Aug. 10 closing price, the updated target implies approximately 2% potential downside
-   Consensus rating remains at “Buy” across 10 covering analysts, with 8 Buys, 2 Holds and 0 Sells

Explore more price target data and ratings for Life360, Inc. on the , and track all previous and future analyst recommendations for Life360, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [LIF.US](https://longbridge.com/en/quote/LIF.US.md)
- [360.AU](https://longbridge.com/en/quote/360.AU.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Does Toro (TTC) Prioritizing Productivity Gains Hint At A Deeper Shift In Its Profit Playbook?](https://longbridge.com/en/news/298119884.md)
- [This “Uninvestable” Stock Returned 3,591% – Here May Be the Next One](https://longbridge.com/en/news/298115144.md)
- [What Bollinger Bands Are Saying About Stocks Right Now](https://longbridge.com/en/news/297783105.md)
- [Nektar Therapeutics (NKTR) Lands Lancet Backing, Is The Upside Already Priced In?](https://longbridge.com/en/news/298137481.md)
- [Paycom (PAYC) Stock Still Looks Below Fair Value While Earnings Look Fair](https://longbridge.com/en/news/297652209.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**